Can men actually get osteoporosis?

Yes. Roughly 1 in 4 men over 50 will break a bone due to osteoporosis in their remaining lifetime, and men who fracture a hip are more likely to die within a year than women who fracture a hip. It is under-diagnosed in men largely because doctors rarely think to screen for it, not because it is rare.

My testosterone came back normal, so why am I still losing bone?

Most lab panels report total testosterone, which includes the large share that is bound to a protein called sex hormone binding globulin and unavailable to your tissue. Only the free, unbound portion can actually reach bone and signal it to rebuild. A man can carry a total number at the top of the normal range while his free testosterone, the part his bones can actually use, is low. Total and free are 2 different numbers, and most panels only report one of them.

Does raising free testosterone with shilajit work like TRT?

No, and this is the important distinction. Testosterone replacement therapy adds more total testosterone from outside the body, which typically shuts down the body's own natural production over time. In a 90-day human trial, men taking shilajit raised their free testosterone by about 19 percent while their own production, measured by LH and FSH, kept running normally. It works with the system already in place rather than replacing it.

Is it safe for a man worried about prostate health?

Shilajit is not a hormone and does not add testosterone from outside the body, which is the mechanism prostate warnings are typically about. Laboratory research has tested shilajit and its fulvic acid directly against cancer cell lines, including prostate-adjacent lines, and found it triggered cancer cell death while leaving healthy cells largely unaffected. That is laboratory, cell-line research, not a human prostate trial, and should be read as exactly that. Any specific concern is worth a conversation with whoever manages your care.

What does the human research show for bone specifically?

A placebo-controlled human trial in people who already had measurable bone loss found that those taking purified shilajit rebuilt bone density over the course of the study, while the placebo group kept losing it. That trial was conducted in postmenopausal women, so it is not a study of men specifically, but it establishes that this mineral can shift human bone density, not just in animals or in a laboratory dish. The free testosterone research below is what closes the male-specific part of the picture.

← Learn

Osteoporosis in Men: The Testosterone Number Almost Nobody Checks

July 28, 2026 · Optimum Research Team

Quick answer: A man can be handed a testosterone lab report that says normal and still be losing bone, because the number on that report is almost always total testosterone, and total is not the number that reaches bone. Only the small free portion, the part not bound up and locked away, can actually deliver the rebuild signal. A 90-day human trial found that shilajit raised free testosterone in men by about 19 percent while their own hormone production kept running, and a separate placebo-controlled human trial found the same mineral rebuilding bone density where placebo kept losing it. Below is the research behind both numbers.

Bone is not a dead frame. It is living tissue

Bone spends your entire life being broken down a little and rebuilt a little. That balance is what a DEXA scan is actually measuring, not a fixed structure slowly wearing away, but the net result of 2 processes running against each other. In a man, the signal that tells bone to lean toward rebuilding is testosterone.

That is why a man who did everything he thought he was supposed to do, calcium, vitamin D, K2, can still watch his bone density fall on the follow-up scan. Those minerals are the bricks. None of them tell the crew to show up and lay them.

The number on your lab report is almost never the number that matters

Here is the part almost no doctor explains, and it is the reason a man can be told his testosterone is fine while his bones keep thinning.

Most of the testosterone circulating in a man's blood is bound to a protein called sex hormone binding globulin, or SHBG. Bound testosterone is inactive. It cannot reach tissue and cannot deliver a signal. Only the small unbound portion, called free testosterone, is available to actually do the job, including telling bone to rebuild.

A standard lab panel reports total testosterone, which is overwhelmingly the bound, locked-up portion. It rarely reports free testosterone at all unless a man specifically asks for it. So the number a man is handed and told is normal can sit at the very top of the reference range while the free portion, the only part his bone can use, has quietly run low for years with no symptom loud enough to raise a flag.

And if a man's total testosterone does come back low, the same story runs sharper. The free portion that reaches bone is lower still, and nothing about a calcium supplement, a vitamin D pill, or a standard bone medication was ever aimed at freeing it up.

The 90-day human trial that measured what raises the free number

In a 90-day randomized human trial in men aged 45 to 55, researchers measured what happened to testosterone when the men took a purified shilajit extract standardized for fulvic acid content. Total testosterone rose by about 20 percent. Free testosterone, the portion that actually reaches tissue, rose by about 19 percent. DHEAS, another marker tied to the body's own hormone production, rose by about 31 percent. Just as importantly, LH and FSH, the pituitary signals that drive natural testosterone production, stayed steady, which means the men's own production kept running rather than being shut down and replaced (https://pubmed.ncbi.nlm.nih.gov/26395129/).

That last detail is what separates this from testosterone replacement therapy. TRT floods the body with testosterone from outside, and the body responds by dialing back its own production, sometimes permanently. This trial measured the opposite pattern. The men's own machinery kept making testosterone while more of it became usable.

What that number means for a man's bone specifically

Raising free testosterone matters because that is the signal bone is waiting on. A related 8-week human trial that biopsied muscle tissue directly in men and women taking shilajit found a cluster of 17 genes involved in tissue repair and the collagen scaffolding that structures and supports bone and connective tissue switched on, with the strongest collagen genes rising roughly 5 times over baseline (https://pubmed.ncbi.nlm.nih.gov/27414521/). That is gene-level evidence of a rebuilding signal being activated, not a mass measurement on its own, and it should be read as exactly that. Read together with the testosterone trial, it points at the same mechanism from 2 different angles, the signal going up and the rebuilding machinery responding.

The bone density trial, and what it does and does not prove for a man

A separate, placebo-controlled human trial tracked people who already had measurable bone loss for close to a year. The group taking purified shilajit saw bone density at the spine and hip increase from where they started, while the placebo group continued to lose density over the same period (https://pubmed.ncbi.nlm.nih.gov/35933897/).

Here is the honest limit of that trial. It was conducted in postmenopausal women, not in men, so it is not direct proof of what happens to a man's DEXA scan on the same mineral. What it does establish, and this matters, is that this mineral can move real human bone density in a controlled trial, not just markers in a rat or cells in a dish. Combine that with the free testosterone trial above, which was conducted in men and measured the exact signal a man's bone runs on, and the 2 pieces close most of the gap between them. Nobody has run a dedicated shilajit bone density trial in men yet. Saying otherwise would be overstating what is actually on the record.

Why the usual bone stack misses this entirely

A man who has already tried to fix his bone density has usually reached for the same things a woman would, calcium, vitamin D, magnesium, zinc, and sometimes boron on the theory that it nudges testosterone. None of those, taken on their own, are aimed at the free testosterone number specifically, and for a lot of men, none of them move it. The bricks pile up with no crew directed to use them.

Prescription bone drugs slow the rate of loss. They are a brake, not a rebuild. And testosterone replacement therapy, while it raises total testosterone, comes with a real tradeoff, it shuts down natural production and chains a man to ongoing treatment, without ever addressing why the free portion ran low to begin with.

For the man worried about prostate risk

Any conversation about testosterone eventually runs into a reasonable question about prostate health, especially for a man who has watched a friend or relative go through a prostate cancer diagnosis. It is worth being precise here. Shilajit is not a hormone and does not add testosterone into the body from outside, which is the mechanism prostate warnings around external testosterone are typically about. It works by freeing up testosterone the body already makes.

Separately, laboratory research has tested shilajit and its fulvic acid against a range of cancer cell lines. A 2026 systematic review found that across multiple cancer cell types, shilajit triggered programmed cell death through a specific cellular pathway while relatively sparing normal, healthy cells in the same experiments (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12866998/). A separate laboratory study found the same pattern in bladder cancer cells, which sit in the same urinary tract region as the prostate, with normal bladder-lining cells tolerating the compound far better than the cancer cells did (https://pmc.ncbi.nlm.nih.gov/articles/PMC8604984/). A third laboratory study specifically included a prostate cancer cell line, LNCaP, among the cancer cells affected by fulvic acid (https://pubmed.ncbi.nlm.nih.gov/27177083/). All of this is laboratory, cell-line research. None of it is a human prostate trial, and none of it should be read as one. It is offered here as exactly what it is, an honest answer to a fair question, not a treatment claim.

Safety and the purity question

Across every human clinical study conducted on shilajit, zero serious adverse events have been reported. It is not a stimulant and it does not act as a synthetic hormone.

Purity is a fair thing to ask about any mineral resin. Optimum shilajit comes from the Altai mountains, cold pressed and purified, and every batch is third-party lab tested for heavy metals and mycotoxins, with results posted. Optimum is a small, family owned company out of Florida, and a real person answers when a customer reaches out. It comes as a box of tablets, not a loose raw powder that loses potency before it reaches the person taking it.

What this actually means for you

If a testosterone panel has ever come back and been called normal while your bone scan kept telling a different story, the 2 numbers are not actually in conflict. They are answering 2 different questions. Total testosterone tells you how much your body is carrying. Free testosterone tells you how much of it your bone can actually use, and for a real share of men, that second number has been running low without anyone checking it.

The research above does not promise a rebuilt skeleton overnight. What it shows is a measured, 19 percent rise in the specific signal bone depends on, in men, without shutting down the body's own production, alongside a separate human trial showing this same mineral rebuilding bone density where placebo could not.

If you want to give your bones the signal a total-only number can hide, you can find Optimum Shilajit here: https://www.liveoptimum.co/products/optimum-shilajit

References

Pandit S, et al. Clinical evaluation of purified Shilajit on testosterone levels in healthy volunteers. Andrologia. 2016. https://pubmed.ncbi.nlm.nih.gov/26395129/
Das A, et al. The human skeletal muscle transcriptome in response to oral shilajit supplementation. Journal of Medicinal Food. 2016. https://pubmed.ncbi.nlm.nih.gov/27414521/
Pingali U, Nutalapati C. Shilajit extract reduces oxidative stress, inflammation, and bone loss to dose-dependently preserve bone mineral density in postmenopausal women with osteopenia, randomized, double-blind, placebo-controlled trial. Phytomedicine. 2022;105:154334. https://pubmed.ncbi.nlm.nih.gov/35933897/
Das S, et al. Shilajit induces apoptosis across multiple cancer cell lines via ROS generation and NF-kB/IKK pathway inhibition, systematic review. Cureus. 2026. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12866998/
Kloskowski T, et al. Cytotoxic effect of Mumio (Shilajit) on urinary bladder cancer cells with relative sparing of normal uroepithelial cells. Scientific Reports. 2021. https://pmc.ncbi.nlm.nih.gov/articles/PMC8604984/
Jayasooriya RGPT, et al. Fulvic acid-stimulated macrophage conditioned media enhanced cell death in multiple human cancer cell lines including LNCaP prostate cancer cells. International Immunopharmacology. 2016. https://pubmed.ncbi.nlm.nih.gov/27177083/